hepatitis recombinant rotavirus live vaccine (6, Wuhan institute of biological products)

重配轮状病毒活疫苗（六价，武汉生物制品研究所）

Report date: 2026/04/03 20:03:44

Base Information

Drug Namehepatitis recombinant rotavirus live vaccine (6, Wuhan institute of biological products)

Drug Alias Name口服六价重配轮状病毒减毒活疫苗（Vero细胞）Reassortant Rotavirus Vaccine, Live, Oral, Hexavalent (Vero Cell)武生儿轮宝

ClassificationVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDiarrheaRotavirus Infections

Global Approved IndicationsRotavirus Infections

Approved Indications in ChinaRotavirus Infections

Original Approved Country/TerritoryMainland China

Original Approved Date2025/08/19

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesWuhan Institute Of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsRotavirus Infections

Inactive IndicationsDiarrhea

Other Information

ATC CodeN/A